"The majority of people who will die of heart disease and heart attacks will never have any symptoms... we need to start screening the world for heart disease." - James Min.
"Cleerly is currently running a large, multi-year clinical trial to prove that its screen can catch heart conditions in people without disease symptoms more accurately than other routine methods."
"If the company succeeds in gaining regulatory clearance to screen large populations, it could be a massive boon for the company, significantly expanding its market reach and revenue."
"An extension round is when a company sells off another chunk of itself at the previous round's price... Cleerly's is growing fast enough." - Scott Barclay.
Collection
[
|
...
]